Thus, immunosuppressive molecules, including programmed death-ligand 1 (PD-L1) and TGF-β1 (Table 1), which facilitate tumor immune evasion, are carried by tumor-derived EVs (Mathew et al., 2020). The gene discussed is CD274; the disease is neoplasm.